See also this year's filing and all EDGAR filings for this company.
PDF Report 0001470915_2014_Pharmagen_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001470915, Pharmagen Inc
| xvar | xval | |
|---|---|---|
| 0 | PropertyPlantAndEquipment | 383,022 |
| 1 | AssetsCurrent | 879,305 |
| 2 | AssetsNonCurrent | 0 |
| 3 | IntangibleAssets | 0 |
| 4 | remainder_Assets | 19,973 |
| 5 | LiabilitiesCurrent | 8,098,506 |
| 6 | LiabilitiesNonCurrent | 0 |
| 7 | remainder_Liabilities | 770,308 |
| 8 | GeneralAndAdministrativeExpense | 2,103,231 |
| 9 | CostOfRevenue | 0 |
| 10 | DepreciationDepletionAndAmortization | 0 |
| 11 | remainder_Expenses | 8,710,431 |
| 12 | remainder_Revenues | 4,813,048 |
| 13 | remainder_NetIncome | 0 |
| 14 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,282,300 |
| 1 | Liabilities | 8,868,814 |
| 2 | Expenses | 10,813,662 |
| 3 | Revenues | 4,813,048 |
| 4 | StockholdersEquity | -7,586,514 |
| 5 | NetIncome | -6,000,614 |
| 6 | ComprehensiveNetIncome | -6,000,614 |
| 7 | BaseVar | 12,888,912 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.42 |
| 9 | EconomicCapitalRatio | 0.138 |
Edgar->Model Mapping
Feature Distribution
Change over Time
